Thymogen vs Cartalax
Side-by-side comparison of Thymogen and Cartalax: mechanism, half-life, dose range, safety profile, and vendor pricing.
Price snapshot
Thymogen
Cartalax
Thymogen
Thymogen (also transliterated Timogen or ╨ó╨╕╨╝╨╛╨│╨╡╨╜) is a synthetic dipeptide — glutamyl-tryptophan (Glu-Trp, or EW) — developed by the St Petersburg Institute of Bioregulation and Gerontology under Professor…
No vendor price on file.
Full Thymogen profileCartalax
Cartalax is a short synthetic peptide developed in Russia by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology, positioned as a "cartilage bioregulator" intended to…
Lowest listed price: $49.99 across 3 listings
Full Cartalax profileSide-by-side comparison
| Attribute | Thymogen | Cartalax |
|---|---|---|
| Category | Recovery | Recovery |
| Research Stage | Approved in Russia / not Western-validated | Preclinical |
| Mechanism of Action | Thymogen's proposed mechanism is best understood in the context of thymic biology and the broader class of thymic peptide immunomodulators. The thymus is the primary organ of T-cell maturation - T-cell progenitors from bone marrow migrate to the thymus,… | Mechanism of Action Cartalax's proposed mechanism is the Khavinson short-peptide framework applied to cartilage: passive membrane permeation, nuclear import, and sequence-selective chromatin modulation producing chondrocyte-favourable transcriptional shifts.… |
| Half-Life | short; not well characterized | No published human or animal pharmacokinetic data for Cartalax. As a small (~446.5 Da) tetrapeptide, rapid plasma hydrolysis (on the order of minutes) is expected, consistent with other Khavinson short peptides, but this has not been directly measured. |
| Typical Dose Range | 50-100 mcg intranasal per nostril 1-2x/day, or 100 mcg SC once daily; 10-day courses, 2-4x/year | 20 mg oral/sublingual once daily for 10 days; 60-90 day washout |
| Dosing Frequency | — | Once daily |
| Administration | — | — |
| Side Effects | Thymogen's side-effect profile in the Russian clinical literature is described as mild and infrequent, consistent with its long history of registered pharmaceutical use in Russia. Users should weight this with modest skepticism given the limitations of the… | Side Effects and Safety Cartalax has been used in Russian clinical settings for roughly 20 years with a sparse adverse-event literature — reassuring in direction, insufficient for confident pharmacovigilance. Reported short-term adverse effects -… |
| Molecular Weight | ~333.3 g/mol (Glu-Trp) | 446.5 Da (C18H30N4O9) |
| Common Vial Sizes | — | — |
Price History
3 data points- Ion Peptide
- Disguised Alpha
- LB
Thymogen: potential benefits
- Immune system modulation
- Thymic function restoration
- Enhanced T-cell immunity
- Immune anti-aging support
Cartalax: potential benefits
- Joint and cartilage repair support
- Connective tissue maintenance
- Anti-aging effects on musculoskeletal system
- Improved joint mobility
Frequently asked
What's the difference between Thymogen and Cartalax?
Thymogen is a recovery that thymogen's proposed mechanism is best understood in the context of thymic biology and the broader class of thymic peptide immunomodulators. the thymus is the primary organ of…. Cartalax is a recovery that mechanism of action cartalax's proposed mechanism is the khavinson short-peptide framework applied to cartilage: passive membrane permeation, nuclear import, and sequence-selective…. The two differ in mechanism, half-life (short; not well characterized vs No published human or animal pharmacokinetic data for Cartalax. As a small (~446.5 Da) tetrapeptide, rapid plasma hydrolysis (on the order of minutes) is expected, consistent with other Khavinson short peptides, but this has not been directly measured.), and typical dose range.
Which has the longer half-life, Thymogen or Cartalax?
Thymogen has a half-life of short; not well characterized. Cartalax has a half-life of No published human or animal pharmacokinetic data for Cartalax. As a small (~446.5 Da) tetrapeptide, rapid plasma hydrolysis (on the order of minutes) is expected, consistent with other Khavinson short peptides, but this has not been directly measured.. Longer half-lives generally mean less frequent dosing but slower on/off kinetics.
Can you stack Thymogen and Cartalax?
Stacking depends on mechanism overlap, safety profile, and goals. Thymogen and Cartalax should only be stacked after reviewing each compound's individual protocol page, side effect profile, and any published interaction data. Use the BodyHackGuide stack builder for a structured review before combining research compounds.
See current vendor prices
Listings from the vendors we track. Prices change often, so check the vendor before you buy.
Before you buy Thymogen or Cartalax
Check the vendor trust score. Every supplier we track is rated 0-100 on COA verification, payment transparency, shipping, reviews, and listings: one published, reproducible methodology, applied to every vendor.
Related comparisons
Research use only. BodyHackGuide is a research and price-comparison reference. The compounds discussed on this page are not approved by the FDA for human consumption and are sold strictly for laboratory research. Prices shown are pulled from vendor listings tracked on BHG and are subject to change. We earn an affiliate commission on some outbound clicks, and every vendor is ranked on the same public, reproducible methodology. See editorial standards and affiliate disclosure.